Patent · US Active

Compositions and methods for inhibition of cathepsins

US9873668B2 · kind B2 · utility

2Cited by
52References
29Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 31, 2016
Grant dateJan 23, 2018
Priority date
Expiry dateAug 31, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C49/786
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention is directed to compound of Formula I and methods of using these compounds in the treatment of conditions in which modulation of a cathepsin, particularly cathepsin K or cathepsin L, will be therapeutically useful.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.